| 标题 |
 IMbrave150: Exploratory efficacy and safety results of hepatocellular carcinoma (HCC) patients (pts) with main trunk and/or contralateral portal vein invasion (Vp4) treated with atezolizumab (atezo) + bevacizumab (bev) versus sorafenib (sor) in a global Ph III study |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Valeriy Vladimirovich Breder; Arndt Vogel; Philippe Merle; Richard S. Finn; Peter R. Galle; et al 出版日期：2021-06-02 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Copyright
Kao
cdercder
Nole
GingerF
OK
Criminology34
无极微光
柏柏
Nexus
爱听歌的谷秋
雪满头
arniu2008
VDC
学术文献互助
丰富的草莓
小透明
Fellow_Lee
WYMD
Puan
皖公网安备34019202002308
